Maarit Hallikainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Maarit Hallikainen has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Helena Gylling
5 shared publications- Helena Gylling
Department of Medicine, Division of Internal Medicine, University of Helsinki, Biomedicum Helsinki C 4 22, P.O. BOX 700, 00029, HUS, Helsinki, Finland
3 shared publications Tatu A. Miettinen
3 shared publicationsEs Sarkkinen
Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
2 shared publications- Jussi Pihlajamäki
Institute of Public Health and Clinical Nutrition University of Eastern Finland Kuopio Finland
2 shared publications Leo Niskanen
2 shared publications
Latest Publications
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 137
653 POSTPRANDIAL SERUM SITOSTANOL AND NON-CHOLESTEROL STEROLS AFTER AN ACUTE DOSE OF PLANT STANOL ESTER ON ITS CHRONIC CONSUMPTION
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 137
653 POSTPRANDIAL SERUM SITOSTANOL AND NON-CHOLESTEROL STEROLS AFTER AN ACUTE DOSE OF PLANT STANOL ESTER ON ITS CHRONIC CONSUMPTION
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (2)
P245 VERY HIGH INTAKE OF PLANT STANOL ESTERS. TIME FOR REVISION OF EFFICACY AND SAFETY?
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (2)
P245 VERY HIGH INTAKE OF PLANT STANOL ESTERS. TIME FOR REVISION OF EFFICACY AND SAFETY?
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e344
Abstract: 583 VERY HIGH PLANT STANOL ESTER INTAKE AND SERUM LIPIDS, STEROLS, LIVER FUNCTION TESTS, CAROTENOIDS, AND FAT SOLUBLE VITAMINS
- 30 June 2009
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (2) , e344
Abstract: 583 VERY HIGH PLANT STANOL ESTER INTAKE AND SERUM LIPIDS, STEROLS, LIVER FUNCTION TESTS, CAROTENOIDS, AND FAT SOLUBLE VITAMINS
- 1 August 2008
- Published by Elsevier in Atherosclerosis
- Vol. 199 (2) , 432-439
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes
- 1 August 2008
- Published by Elsevier in Atherosclerosis
- Vol. 199 (2) , 432-439
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes
- 1 August 2008
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 23 (4) , 429-435
Effect of Parenteral Serum Plant Sterols on Liver Enzymes and Cholesterol Metabolism in a Patient With Short Bowel Syndrome
Hepatobiliary complications are common during parenteral nutrition. Lipid moiety in commercially available solutions contains plant sterols. It is not known whether plant sterols in parenteral nutrition interfere with hepatic function in adults. We detected how different amounts of plant sterols in parenteral nutrition solution affected serum plant sterol concentrations and liver enzymes during a 1.5-year follow-up in a patient with short bowel syndrome. Serum lipid, plant sterol, and liver enzyme levels were measured regularly during the transition from Intralipid (100% soy-based intravenous fat emulsion) to ClinOleic (an olive oil–based intravenous fat emulsion with 80% olive oil, 20% soy oil and lower plant sterols); the lipid supply was also gradually increased from 20 to 35 g/d. Plant sterols in parenteral nutrition solution and serum were measured with gas-liquid chromatography. During infusion of soy-based intravenous fat emulsion (30 g/d, total plant sterols 87 mg/d), the concentrations of sitosterol, campesterol, and stigmasterol were 4361, 1387, and 378 μg/dL, respectively, and serum liver enzyme values were ≥ 2.5 times above upper limit of normal. After changing to olive oil–based intravenous fat emulsion (20-35 g/d, plant sterols 37-65 mg/d), concentrations decreased to 2148 to 2251 μg/dL for sitosterol, 569-297 μg/dL for campesterol, and 95-55 μg/dL for stigmasterol. Concomitantly, liver enzyme values decreased to 1.4 to 1.8 times above upper limit of normal at the end of follow-up. The nutrition status of the patient improved. The amount of plant sterols in lipid emulsion affects serum liver enzyme levels more than the amount of lipid.
- 1 August 2008
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 23 (4) , 429-435
Effect of Parenteral Serum Plant Sterols on Liver Enzymes and Cholesterol Metabolism in a Patient With Short Bowel Syndrome
Hepatobiliary complications are common during parenteral nutrition. Lipid moiety in commercially available solutions contains plant sterols. It is not known whether plant sterols in parenteral nutrition interfere with hepatic function in adults. We detected how different amounts of plant sterols in parenteral nutrition solution affected serum plant sterol concentrations and liver enzymes during a 1.5-year follow-up in a patient with short bowel syndrome. Serum lipid, plant sterol, and liver enzyme levels were measured regularly during the transition from Intralipid (100% soy-based intravenous fat emulsion) to ClinOleic (an olive oil–based intravenous fat emulsion with 80% olive oil, 20% soy oil and lower plant sterols); the lipid supply was also gradually increased from 20 to 35 g/d. Plant sterols in parenteral nutrition solution and serum were measured with gas-liquid chromatography. During infusion of soy-based intravenous fat emulsion (30 g/d, total plant sterols 87 mg/d), the concentrations of sitosterol, campesterol, and stigmasterol were 4361, 1387, and 378 μg/dL, respectively, and serum liver enzyme values were ≥ 2.5 times above upper limit of normal. After changing to olive oil–based intravenous fat emulsion (20-35 g/d, plant sterols 37-65 mg/d), concentrations decreased to 2148 to 2251 μg/dL for sitosterol, 569-297 μg/dL for campesterol, and 95-55 μg/dL for stigmasterol. Concomitantly, liver enzyme values decreased to 1.4 to 1.8 times above upper limit of normal at the end of follow-up. The nutrition status of the patient improved. The amount of plant sterols in lipid emulsion affects serum liver enzyme levels more than the amount of lipid.
- 1 August 2007
- Published by Elsevier in Clinica Chimica Acta
- Vol. 383 (1-2) , 126-132
Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome
- 1 August 2007
- Published by Elsevier in Clinica Chimica Acta
- Vol. 383 (1-2) , 126-132
Serum adipokines are associated with cholesterol metabolism in the metabolic syndrome
- 31 December 2006
- Published by Elsevier in Clinica Chimica Acta
- Vol. 374 (1-2) , 63-68
Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption
- 31 December 2006
- Published by Elsevier in Clinica Chimica Acta
- Vol. 374 (1-2) , 63-68
Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption
- Open Access
- 1 December 2006
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 84 (6) , 1385-1392
Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome
Background: Carbohydrate modification based on rye bread and pasta enhances early insulin secretion in subjects with the metabolic syndrome. Objective: Because the actions of insulin and cholesterol metabolism are interrelated, the question is raised of whether it is possible to alter cholesterol metabolism by means of dietary carbohydrate modification. Design: We investigated the 12-wk effects of dietary carbohydrate modification on cholesterol synthesis and absorption by measuring the ratios of surrogate markers of precursor (cholestenol, desmosterol, and lathosterol) and absorption (cholestanol and plant sterols) sterols to cholesterol and their association to glucose metabolism in 74 subjects with the metabolic syndrome. The subjects were randomly assigned to diets with rye bread and pasta (RPa) or oat, wheat bread, and potato (OWPo) as the main carbohydrate source (34% and 37% of energy intake, respectively). Results: During the study, serum cholesterol concentrations remained unchanged. Cholesterol synthesis was lower (6–10% for cholestenol and lathosterol; P < 0.05) and absorption higher (9%; P < 0.05 for sitosterol) with the OWPo diet than at baseline. With the RPa diet, cholesterol absorption was lower and synthesis higher than with the OWPo diet. The increment in the glucose area under the curve with the RPa diet was positively related to baseline cholesterol synthesis (eg, lathosterol; r = 0.480, P < 0.05) and negatively to absorption (for cholestanol; r = −0.520, P < 0.05). In the combined group, the changes in the cholestanol ratio and the insulinogenic index were interrelated (r = −0.464, P < 0.001). Conclusions: Carbohydrate modifications had dissimilar effects on cholesterol metabolism. Consumption of RPa, as compared with OWPo, may be clinically more favorable because it seems to inhibit the absorption of cholesterol, a factor crucial in the development of arterial atherosclerosis.
- 1 December 2006
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 84 (6) , 1385-1392
Open AccessInteraction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome
Background: Carbohydrate modification based on rye bread and pasta enhances early insulin secretion in subjects with the metabolic syndrome. Objective: Because the actions of insulin and cholesterol metabolism are interrelated, the question is raised of whether it is possible to alter cholesterol metabolism by means of dietary carbohydrate modification. Design: We investigated the 12-wk effects of dietary carbohydrate modification on cholesterol synthesis and absorption by measuring the ratios of surrogate markers of precursor (cholestenol, desmosterol, and lathosterol) and absorption (cholestanol and plant sterols) sterols to cholesterol and their association to glucose metabolism in 74 subjects with the metabolic syndrome. The subjects were randomly assigned to diets with rye bread and pasta (RPa) or oat, wheat bread, and potato (OWPo) as the main carbohydrate source (34% and 37% of energy intake, respectively). Results: During the study, serum cholesterol concentrations remained unchanged. Cholesterol synthesis was lower (6–10% for cholestenol and lathosterol; P < 0.05) and absorption higher (9%; P < 0.05 for sitosterol) with the OWPo diet than at baseline. With the RPa diet, cholesterol absorption was lower and synthesis higher than with the OWPo diet. The increment in the glucose area under the curve with the RPa diet was positively related to baseline cholesterol synthesis (eg, lathosterol; r = 0.480, P < 0.05) and negatively to absorption (for cholestanol; r = −0.520, P < 0.05). In the combined group, the changes in the cholestanol ratio and the insulinogenic index were interrelated (r = −0.464, P < 0.001). Conclusions: Carbohydrate modifications had dissimilar effects on cholesterol metabolism. Consumption of RPa, as compared with OWPo, may be clinically more favorable because it seems to inhibit the absorption of cholesterol, a factor crucial in the development of arterial atherosclerosis.
- 1 October 2006
- Published by Elsevier in Atherosclerosis
- Vol. 188 (2) , 425-432
Endothelial function in hypercholesterolemic subjects: Effects of plant stanol and sterol esters
- 1 October 2006
- Published by Elsevier in Atherosclerosis
- Vol. 188 (2) , 425-432
Endothelial function in hypercholesterolemic subjects: Effects of plant stanol and sterol esters
- Open Access
- 27 August 2002
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 2 (1) , 14
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
- 27 August 2002
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 2 (1) , 14
Open AccessShort-term LDL cholesterol-lowering efficacy of plant stanol esters